Literature DB >> 23801876

Gastric body diaphragm-like stricture as a rare complication of nonsteroidal anti-inflammatory drugs.

Li-Li Wu1, Yun-Sheng Yang, Feng-Chun Cai, Shu-Fang Wang.   

Abstract

Increased risk due to nonsteroidal anti-inflammatory drugs (NSAIDs) therapy has been observed in patients. Although diaphragm-like stricture in the small bowel and colon induced by NSAIDs therapy has been rarely reported, gastric body diaphragm-like stricture has not been reported. We describe the first case of gastric body diaphragm-like stricture due to NSAIDs in a 44-year-old male patient who was successfully treated by an endoscopic approach to avoid complicated surgery. This case highlights new insight into the disadvantages of NSAIDs and provides new data for future clinical studies.

Entities:  

Keywords:  Diaphragm; Gastric; Gastroscopy; Nonsteroidal anti-inflammatory drug; Stricture

Mesh:

Substances:

Year:  2013        PMID: 23801876      PMCID: PMC3691042          DOI: 10.3748/wjg.v19.i23.3703

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  24 in total

1.  Histopathology of diaphragm disease of the small intestine: a study of 10 cases from a single institution.

Authors:  Giovanni De Petris; José I López
Journal:  Am J Clin Pathol       Date:  2008-10       Impact factor: 2.493

2.  Gastrocolic fistula related to NSAID-induced gastric ulcer.

Authors:  Joseph C Yarze
Journal:  Gastrointest Endosc       Date:  2011-05-31       Impact factor: 9.427

3.  Clinical and endoscopic features of nonsteroidal anti-inflammatory drug-induced colonic ulcerations.

Authors:  K Kurahara; T Matsumoto; M Iida; K Honda; T Yao; M Fujishima
Journal:  Am J Gastroenterol       Date:  2001-02       Impact factor: 10.864

Review 4.  Preventing the gastrointestinal adverse effects of nonsteroidal anti-inflammatory drugs: from risk factor identification to risk factor intervention.

Authors:  Marc Bardou; Alan N Barkun
Journal:  Joint Bone Spine       Date:  2009-12-21       Impact factor: 4.929

5.  Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.

Authors:  F E Silverstein; G Faich; J L Goldstein; L S Simon; T Pincus; A Whelton; R Makuch; G Eisen; N M Agrawal; W F Stenson; A M Burr; W W Zhao; J D Kent; J B Lefkowith; K M Verburg; G S Geis
Journal:  JAMA       Date:  2000-09-13       Impact factor: 56.272

6.  Non-steroidal anti-inflammatory drug-induced colopathy.

Authors:  Mads Klein; Dorte Linnemann; Jacob Rosenberg
Journal:  BMJ Case Rep       Date:  2011-02-08

Review 7.  Nonsteroidal antiinflammatory drug-related injury to the gastrointestinal tract: clinical picture, pathogenesis, and prevention.

Authors:  Carmelo Scarpignato; Richard H Hunt
Journal:  Gastroenterol Clin North Am       Date:  2010-09       Impact factor: 3.806

8.  Famotidine is inferior to pantoprazole in preventing recurrence of aspirin-related peptic ulcers or erosions.

Authors:  Fook-Hong Ng; Siu-Yin Wong; Kwok-Fai Lam; Wai-Ming Chu; Pierre Chan; Yuk-Hei Ling; Carolyn Kng; Wai-Cheung Yuen; Yuk-Kong Lau; Ambrose Kwan; Benjamin C Y Wong
Journal:  Gastroenterology       Date:  2009-11-11       Impact factor: 22.682

9.  Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study.

Authors:  Laurence Maiden; Bjarni Thjodleifsson; Anna Seigal; Ingvar Iain Bjarnason; David Scott; Sigurbjorn Birgisson; Ingvar Bjarnason
Journal:  Clin Gastroenterol Hepatol       Date:  2007-07-10       Impact factor: 11.382

10.  Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term non-steroidal anti-inflammatory drug (NSAID) therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial.

Authors:  Kentaro Sugano; Teiji Kontani; Shinichi Katsuo; Yoshinori Takei; Nobuhiro Sakaki; Kiyoshi Ashida; Yuji Mizokami; Masahiro Asaka; Shigeyuki Matsui; Tatsuya Kanto; Satoshi Soen; Tsutomu Takeuchi; Hideyuki Hiraishi; Naoki Hiramatsu
Journal:  J Gastroenterol       Date:  2012-03-03       Impact factor: 7.527

View more
  2 in total

Review 1.  Gut inflammation induced by drugs: Can pathology help to differentiate from inflammatory bowel disease?

Authors:  Naoimh Herlihy; Roger Feakins
Journal:  United European Gastroenterol J       Date:  2022-05-28       Impact factor: 6.866

2.  Gene expression analysis in NSAID-induced rat small intestinal disease model with the intervention of berberine by the liquid chip technology.

Authors:  Guanqun Chao; Qianqian Wang; Fangxu Ye; Shuo Zhang
Journal:  Genes Environ       Date:  2021-07-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.